199 related articles for article (PubMed ID: 17684131)
1. Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.
Sutcliffe S; Giovannucci E; Gaydos CA; Viscidi RP; Jenkins FJ; Zenilman JM; Jacobson LP; De Marzo AM; Willett WC; Platz EA
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1573-80. PubMed ID: 17684131
[TBL] [Abstract][Full Text] [Related]
2. Sexually transmissible infections and prostate cancer risk.
Huang WY; Hayes R; Pfeiffer R; Viscidi RP; Lee FK; Wang YF; Reding D; Whitby D; Papp JR; Rabkin CS
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2374-81. PubMed ID: 18768506
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study.
Naucler P; Chen HC; Persson K; You SL; Hsieh CY; Sun CA; Dillner J; Chen CJ
J Gen Virol; 2007 Mar; 88(Pt 3):814-822. PubMed ID: 17325353
[TBL] [Abstract][Full Text] [Related]
4. Association of Chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: the HPV in men study.
Alberts CJ; Schim van der Loeff MF; Papenfuss MR; da Silva RJ; Villa LL; Lazcano-Ponce E; Nyitray AG; Giuliano AR
Sex Transm Dis; 2013 Jun; 40(6):508-15. PubMed ID: 23680908
[TBL] [Abstract][Full Text] [Related]
5. Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study.
Hrbacek J; Urban M; Hamsikova E; Tachezy R; Eis V; Brabec M; Heracek J
BMC Cancer; 2011 Feb; 11():53. PubMed ID: 21291519
[TBL] [Abstract][Full Text] [Related]
6. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer.
Sutcliffe S; Giovannucci E; Alderete JF; Chang TH; Gaydos CA; Zenilman JM; De Marzo AM; Willett WC; Platz EA
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):939-45. PubMed ID: 16702374
[TBL] [Abstract][Full Text] [Related]
7. Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection.
Simen-Kapeu A; Kataja V; Yliskoski M; Syrjänen K; Dillner J; Koskela P; Paavonen J; Lehtinen M
Scand J Infect Dis; 2008; 40(9):745-51. PubMed ID: 19086247
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.
Korodi Z; Dillner J; Jellum E; Lumme S; Hallmans G; Thoresen S; Hakulinen T; Stattin P; Luostarinen T; Lehtinen M; Hakama M
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2952-5. PubMed ID: 16365015
[TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women.
Kim S; Arduino JM; Roberts CC; Marsico M; Liaw KL; Skjeldestad FE
Sex Transm Dis; 2011 Jul; 38(7):587-97. PubMed ID: 21301390
[TBL] [Abstract][Full Text] [Related]
10. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.
Madeleine MM; Anttila T; Schwartz SM; Saikku P; Leinonen M; Carter JJ; Wurscher M; Johnson LG; Galloway DA; Daling JR
Int J Cancer; 2007 Feb; 120(3):650-5. PubMed ID: 17096345
[TBL] [Abstract][Full Text] [Related]
11. Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer.
Hoffman LJ; Bunker CH; Pellett PE; Trump DL; Patrick AL; Dollard SC; Keenan HA; Jenkins FJ
J Infect Dis; 2004 Jan; 189(1):15-20. PubMed ID: 14702148
[TBL] [Abstract][Full Text] [Related]
12. Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil.
da Silva Barros NK; Costa MC; Alves RR; Villa LL; Derchain SF; Zeferino LC; Dos Santos Carneiro MA; Rabelo-Santos SH
J Med Virol; 2012 Jul; 84(7):1143-50. PubMed ID: 22585734
[TBL] [Abstract][Full Text] [Related]
13. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines.
Smith JS; Muñoz N; Herrero R; Eluf-Neto J; Ngelangel C; Franceschi S; Bosch FX; Walboomers JM; Peeling RW
J Infect Dis; 2002 Feb; 185(3):324-31. PubMed ID: 11807714
[TBL] [Abstract][Full Text] [Related]
14. Population-Based Study of Prediagnostic Antibodies to Chlamydia trachomatis in Relation to Adverse Pregnancy Outcome.
Rantsi T; Joki-Korpela P; Wikström E; Öhman H; Bloigu A; Lehtinen M; Gissler M; Tiitinen A; Paavonen J; Surcel HM
Sex Transm Dis; 2016 Jun; 43(6):382-7. PubMed ID: 27196260
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.
Sutcliffe S; Viscidi RP; Till C; Goodman PJ; Hoque AM; Hsing AW; Thompson IM; Zenilman JM; De Marzo AM; Platz EA
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):614-8. PubMed ID: 20142255
[TBL] [Abstract][Full Text] [Related]
16. Maternal exposure to sexually transmitted infections and schizophrenia among offspring.
Cheslack-Postava K; Brown AS; Chudal R; Suominen A; Huttunen J; Surcel HM; Sourander A
Schizophr Res; 2015 Aug; 166(1-3):255-60. PubMed ID: 26022653
[TBL] [Abstract][Full Text] [Related]
17. No serological evidence of association between prostate cancer and infection with herpes simplex virus type 2 or human herpesvirus type 8: a nested case-control study.
Korodi Z; Wang X; Tedeschi R; Knekt P; Dillner J
J Infect Dis; 2005 Jun; 191(12):2008-11. PubMed ID: 15897985
[TBL] [Abstract][Full Text] [Related]
18. Order of HPV/Chlamydia infections and cervical high-grade precancer risk: a case-cohort study.
Luostarinen T; Namujju PB; Merikukka M; Dillner J; Hakulinen T; Koskela P; Paavonen J; Surcel HM; Lehtinen M
Int J Cancer; 2013 Oct; 133(7):1756-9. PubMed ID: 23526412
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study.
Smith JS; Bosetti C; Muñoz N; Herrero R; Bosch FX; Eluf-Neto J; Meijer CJ; Van Den Brule AJ; Franceschi S; Peeling RW;
Int J Cancer; 2004 Sep; 111(3):431-9. PubMed ID: 15221973
[TBL] [Abstract][Full Text] [Related]
20. Chlamydial antibodies and risk of prostate cancer.
Anttila T; Tenkanen L; Lumme S; Leinonen M; Gislefoss RE; Hallmans G; Thoresen S; Hakulinen T; Luostarinen T; Stattin P; Saikku P; Dillner J; Lehtinen M; Hakama M
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):385-9. PubMed ID: 15734962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
